CHONGQING, CHINA - JULY 30: In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS), an American telehealth company offering personal care ...

Just a couple of months after launching a partnership with direct-to-consumer telehealth company Hims & Hers, Novo Nordisk is terminating the collaboration, the company announced on Monday. The drug ...

Hims & Hers stock (NYSE: HIMS) increased by 16% yesterday following its announcement about expanding into the treatment of menopause and perimenopause—a strategic shift indicating that the company is ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, positions itself as a consumer-first health and wellness platform, designed to transform the way individuals access and manage ...

Hims & Hers Health Inc. HIMS shares are trading lower Tuesday after GoodRx Inc. GDRX announced a collaboration with Novo Nordisk to provide discounted access to two of the most in-demand GLP-1 drugs, ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, has been leveraging existing capabilities and continuing to expand capabilities to penetrate new sales channels and further ...